Tuesday 15 September 2015

Sun Pharma climbs 0.64%; to sell facility in Ireland

The company plans to sell a manufacturing facility in Ireland that was owned by Ranbaxy, which has been acquired by the Indian drug major.


Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 862.65, up by 0.64% from its previous closing of Rs. 857.05 on the BSE.

The company plans to sell a manufacturing facility in Ireland that was owned by Ranbaxy , which has been acquired by the Indian drug major. 

The scrip opened at Rs. 858.6 and has touched a high and low of Rs. 865.5 and Rs. 855 respectively. So far 188732 shares were traded on the counter. The current market cap of the company is Rs. 206248.75 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.8 on 07-Apr-2015 and a 52 week low of Rs. 748 on 26-Sep-2014. Last one week high and low of the scrip stood at Rs. 860 and Rs. 815 respectively.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 31.51 % and 13.78 % respectively.

The stock is currently trading above its 200 DMA.

No comments:

Post a Comment